642 related articles for article (PubMed ID: 26035321)
1. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
Labo N; Miley W; Benson CA; Campbell TB; Whitby D
AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
[TBL] [Abstract][Full Text] [Related]
2. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
3. Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.
Olp LN; Minhas V; Gondwe C; Kankasa C; Wojcicki J; Mitchell C; West JT; Wood C
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26185193
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.
Liu Z; Fang Q; Zhou S; Minhas V; Wood C; He N; Zhang T
J Med Virol; 2017 Sep; 89(9):1629-1635. PubMed ID: 28252177
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
7. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.
Fu B; Sun F; Li B; Yang L; Zeng Y; Sun X; Xu F; Rayner S; Guadalupe M; Gao SJ; Wang L
J Med Virol; 2009 Aug; 81(8):1422-31. PubMed ID: 19551832
[TBL] [Abstract][Full Text] [Related]
11. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.
Olsen SJ; Chang Y; Moore PS; Biggar RJ; Melbye M
AIDS; 1998 Oct; 12(14):1921-5. PubMed ID: 9792393
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.
Kourí V; Eng SM; Rodríguez ME; Resik S; Orraca O; Moore PS; Chang Y
Rev Panam Salud Publica; 2004 May; 15(5):320-5. PubMed ID: 15231079
[TBL] [Abstract][Full Text] [Related]
13. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
Blumenthal MJ; Schutz C; Barr D; Locketz M; Marshall V; Whitby D; Katz AA; Uldrick T; Meintjes G; Schäfer G
J Infect Dis; 2019 Jul; 220(5):841-851. PubMed ID: 31004430
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection.
Campbell TB; Fitzpatrick L; MaWhinney S; Zhang X; Schooley RT
J Acquir Immune Defic Syndr; 1999 Dec; 22(4):333-40. PubMed ID: 10634194
[TBL] [Abstract][Full Text] [Related]
15. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti.
Marcelin AG; Grandadam M; Flandre P; Nicand E; Milliancourt C; Koeck JL; Philippon M; Teyssou R; Agut H; Dupin N; Calvez V
J Med Virol; 2002 Oct; 68(2):164-7. PubMed ID: 12210403
[TBL] [Abstract][Full Text] [Related]
17. Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men.
Casper C; Wald A; Pauk J; Tabet SR; Corey L; Celum CL
J Infect Dis; 2002 Apr; 185(7):990-3. PubMed ID: 11920325
[TBL] [Abstract][Full Text] [Related]
18. A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease.
Greensill J; Sheldon JA; Murthy KK; Bessonette JS; Beer BE; Schulz TF
AIDS; 2000 Dec; 14(17):F129-35. PubMed ID: 11125908
[TBL] [Abstract][Full Text] [Related]
19. High Seroprevalence of Human Herpesvirus 8 Infection in HIV-positive Homosexual Men in Jiangsu Province, China.
Li J; Song J; Tan G; Wang J; Zhou Z; Wu X
Curr HIV Res; 2017; 15(4):273-278. PubMed ID: 28606034
[TBL] [Abstract][Full Text] [Related]
20. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F
J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
